| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/18/2007 | EP1079843B1 Use of alfa1beta1 integrin receptor inhibitors and tgf- beta1 inhibitors in the treatment of kidney disease |
| 04/18/2007 | EP1052259B1 Novel optically active aminopentane derivative |
| 04/18/2007 | EP0960117B1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE |
| 04/18/2007 | CN1950389A Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 04/18/2007 | CN1950374A Tetraazabenzo[e]azulene derivatives and analogs thereof |
| 04/18/2007 | CN1950372A 咪唑并吡啶化合物 Imidazopyridine compound |
| 04/18/2007 | CN1950343A Basic amine compound and use thereof |
| 04/18/2007 | CN1950109A Compositions comprising cells and magnetic materials for targeted delivery |
| 04/18/2007 | CN1311081C Stem cell differentiation |
| 04/18/2007 | CN1310948C Modified peptides as therapeutic agents |
| 04/18/2007 | CN1310947C Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use as the rapentics |
| 04/18/2007 | CN1310942C Suppressor gene |
| 04/18/2007 | CN1310940C Process for producing triterpene derivative |
| 04/18/2007 | CN1310922C Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 04/18/2007 | CN1310921C Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/18/2007 | CN1310919C 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
| 04/18/2007 | CN1310916C Hetero-bicyclic compounds |
| 04/18/2007 | CN1310909C Novel heteroaryl derivatives, their prepn. and use |
| 04/18/2007 | CN1310906C Indole-type derivatives as inhibitors of p38 kinase |
| 04/18/2007 | CN1310904C Tricyclic alkylhydroxamates, their preparation and thier use as well proliferation inhibitors |
| 04/18/2007 | CN1310890C Isoquinoline derivatives |
| 04/18/2007 | CN1310885C Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative |
| 04/18/2007 | CN1310881C New 3-aryl-2-hydroxypropionic acid derivative I |
| 04/18/2007 | CN1310872C Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
| 04/18/2007 | CN1310679C Method of achieving persistent transgene expression |
| 04/18/2007 | CN1310673C Composition of multiple scattered mixture contg.polypeptide and its pharm compsn. |
| 04/18/2007 | CN1310672C Osteogenis oligopeptide as blood-formation stimulation articles |
| 04/18/2007 | CN1310671C Sustained-release compositions for injection and process for producing the same |
| 04/18/2007 | CN1310643C Composition comprising a cholesterol absorption inhibitor, an HMG-CoA reductase inhibitor and a stabilizing agent |
| 04/17/2007 | USRE39576 Inhibitors of inducible nitric oxide synthase, as hypotensive agent, antiinflammatory agent, antiarthritic agent |
| 04/17/2007 | USRE39575 For therapy of sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators |
| 04/17/2007 | USRE39574 Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies |
| 04/17/2007 | US7205417 Spiro compounds |
| 04/17/2007 | US7205407 3-Substituted oxindole β3 agonists |
| 04/17/2007 | US7205403 Preferential G protein coupled receptor antagonists, such as 8-(3-amino-1-methyl-1H-pyrazol-5-yl)-1,3-dipropyl-3,7-dihydro -1H-purine-2,6-dione, used for prophylaxis of asthma, autoimmune diseases or retinopathy |
| 04/17/2007 | US7205392 Synergistic mixture of glycoprotein and angiogenesis inhibitor |
| 04/17/2007 | US7205386 Truncated CD200 |
| 04/17/2007 | US7205333 Therapy for influenza virus; inhaler |
| 04/17/2007 | US7205327 Benzoimidazole or imidazole-2-carbonyl)-amino)-3-methyl butyrylamino)-5-fluoro-4-oxo- derivatives |
| 04/17/2007 | US7205324 IMPDH (inosine-5'-monophosphate dehydrogenase); transplant rejection and autoimmune diseases |
| 04/17/2007 | US7205319 N-[phenyl (piperidin-2-yl) methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
| 04/17/2007 | US7205314 Compounds for the treatment of dementia related diseases |
| 04/17/2007 | US7205312 As inhibitors of the retinoic acid-metabolism, as drugs; breast cancer; psoriasis |
| 04/17/2007 | US7205311 Therapeutic acridone and acridine compounds |
| 04/17/2007 | US7205309 Obesity therapy; administering orlistat |
| 04/17/2007 | US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis |
| 04/17/2007 | US7205302 Anticoagulants; antilipemic agents; cardiovascular disorders |
| 04/17/2007 | US7205300 Aryl fused azapolycyclic compounds |
| 04/17/2007 | US7205280 Methods of suppressing microglial activation |
| 04/17/2007 | US7205151 Antiinflammatory agents; skin disorders |
| 04/17/2007 | US7205127 Methods of treating insulin resistance with an inhibitor of an NAD(P)H oxidase |
| 04/17/2007 | US7205120 Detection Alzheimer's disease |
| 04/17/2007 | US7205107 CATT-tetranucleotide repeat polymorphism at position-817 of the human Mif gene that functionally affects the activity of the Macrophage Inhibitory Factor (MIF) promoter in gene reporter assays |
| 04/17/2007 | CA2407759C Substituted phenylacetamides and their use as glucokinase activators |
| 04/17/2007 | CA2386799C Fused cycloheptane and fused azacycloheptane compounds and their as integrin receptor antagonists |
| 04/17/2007 | CA2374635C Sulfuric acid mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester |
| 04/17/2007 | CA2371645C Naphtalene or heterocyclically substituted benzimidazoles as parp inhibitors |
| 04/17/2007 | CA2358885C Pyrazolecarboxylic acid derivatives, their preparation, pharmaceutical compositions containing them |
| 04/17/2007 | CA2350073C Ccr5 modulators |
| 04/17/2007 | CA2341690C Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 04/17/2007 | CA2318381C Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 04/17/2007 | CA2280960C Oxirancarboxylic acids for the treatment of diabetes |
| 04/17/2007 | CA2271085C Indolecarboxylic compounds and their use as pharmaceutical compounds |
| 04/17/2007 | CA2250586C Meta-substituted phenylene sulphonamide derivatives |
| 04/17/2007 | CA2203412C Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
| 04/17/2007 | CA2196197C Retinoic acid x-receptor ligands |
| 04/17/2007 | CA2190765C Novel potent inducers of terminal differentiation and methods of use thereof |
| 04/17/2007 | CA2166292C Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 04/17/2007 | CA2153789C Biologically active tgf-.beta.1 and tgf-.beta.2 peptides |
| 04/12/2007 | WO2007040240A1 Optically active cyclic alcohol compound and method for producing same |
| 04/12/2007 | WO2007040212A1 Neuronal differentiation inhibitor peptide and use thereof |
| 04/12/2007 | WO2007040208A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
| 04/12/2007 | WO2007040128A1 Therapeutic agent for heart failure |
| 04/12/2007 | WO2007040082A1 Pharmaceutical composition for treatment or prevention of nephritis and method for producing same |
| 04/12/2007 | WO2007040006A1 Activator for peroxisome proliferator-activated receptor (pparϝ) and composition containing the activator for preventing or ameliorating specific symptom |
| 04/12/2007 | WO2007040005A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPARα) AND COMPOSITION CONTAINING THE ACTIVATOR FOR PREVENTING OR AMELIORATING SPECIFIC SYMPTOM |
| 04/12/2007 | WO2007039976A1 Abnormal protein removing composition |
| 04/12/2007 | WO2007039114A1 Novel nitrocatechol derivatives having selectin ligand activity |
| 04/12/2007 | WO2007011843A3 Prevention and treatment of ophthalmic complications of diabetes |
| 04/12/2007 | US20070083045 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase |
| 04/12/2007 | US20070082957 2-chloro-5-(3-oxopropyl)-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-benzamide; P2X7 receptor antagonists; inflammatory, immune or cardiovascular diseases |
| 04/12/2007 | US20070082938 Polymorphs of bicifadine hydrochloride |
| 04/12/2007 | US20070082927 Piperidine derivative having nmda receptor antagonistic activity |
| 04/12/2007 | US20070082921 Quinazoline derivatives as antitumor agents |
| 04/12/2007 | US20070082912 Pyrrole compounds for the treatment of prostaglandine mediated diseases |
| 04/12/2007 | US20070082910 Specific nad(p)h oxidase inhibitor |
| 04/12/2007 | US20070082908 Bicycle pyrazole derivative |
| 04/12/2007 | US20070082897 Acylated indanyl amines and their use as pharmaceuticals |
| 04/12/2007 | US20070082872 Indole-containing compounds with anti-tubulin and vascular targeting activity |
| 04/12/2007 | US20070082341 Human phospholipases |
| 04/12/2007 | US20070082077 Inhibitor of glucose absorption and method for producing the same |
| 04/12/2007 | US20070082068 Il-8 production promoters and use thereof |
| 04/12/2007 | US20070082041 Topical delivery of codrugs |
| 04/12/2007 | US20070082013 Use of botulinum toxin for producing drug for preventing or treating final phase of lung troubles |
| 04/12/2007 | US20070081973 Cytokine polypeptides |
| 04/12/2007 | US20070081970 G-csf-containing substance for fibroblast recruitment and g-csf-contianing therapeutic agent for wound healing |
| 04/12/2007 | US20070081942 Gene differentially expressed in breast and bladder cancer, and encoded polypeptides |
| 04/12/2007 | DE112005001235T5 Zusammensetzung mit Moxibustions-Effekt und komprimiertes Pellet, das dieselbe verwendet Composition with moxibustion effects and compressed pellet, using the same |
| 04/12/2007 | DE112005000737T5 Mit Heparansulfat-Zuckerketten modifizierte Heparin-bindende Proteine, Verfahren zur Erzeugung derselben und Arzneimittel, welche dieselben enthalten With heparan sulfate sugar chains modified heparin-binding proteins, methods for producing the same and pharmaceutical compositions containing the same |
| 04/12/2007 | CA2625340A1 Pharmaceutical composition for treatment or prevention of nephritis and method for producing same |